logo
Select company
Select metric
$ 77KCapital Expenditure
VS
Market
80
Sector
64
Industry
53
History
100
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 77K
3/31/2025$ 87K
12/31/2024$ 182K
9/30/2024$ 96K
6/30/2024$ 108K
3/31/2024$ 966K
12/31/2023$ 988K
9/30/2023$ 1.14M
6/30/2023$ 1.22M
3/31/2023$ 554K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) CapEx stands at $ 140K.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average CapEx has been $ 539.1K.
  • The median CapEx for ARBUTUS BIOPHARMA CORP during this period was $ 464K
  • ARBUTUS BIOPHARMA CORP reached its highest CapEx over the past 5 years at $ 1.22M.
  • The lowest CapEx recorded by ARBUTUS BIOPHARMA CORP in the same timeframe $ 77K

ARBUTUS BIOPHARMA CORP's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
ZBIO : ZENAS BIOPHARMA INC $ 92KQURE : UNIQURE NV $ 9.13MNUVB : NUVATION BIO INC $ 388KVIR : VIR BIOTECHNOLOGY INC $ 6.14MBCYC : BICYCLE THERAPEUTICS PLC $ 1.91MIMNM : IMMUNOME INC $ 7.24MRLAY : RELAY THERAPEUTICS INC $ 637KCAPR : CAPRICOR THERAPEUTICS INC $ 3.38MALMS : ALUMIS INC $ 1.8MTSHA : TAYSHA GENE THERAPIES INC $ 413K

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

ABUS - Capital Expenditure, Last 5 years

$ 77K

Minimum

Jun 30, 2025

$ 1.22M

Maximum

Jun 30, 2023

$ 539.1K

Average

$ 464K

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.66M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.66M
median$ 1.92M
std$ 15.86M